Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial

Open access

Abstract

BACKGROUND: Undiagnosed tuberculosis (TB) remains the most common cause of HIV-related mortality. Xpert MTB/RIF (Xpert) is being rolled out globally to improve TB diagnostic capacity. However, previous Xpert impact trials have reported that health system weaknesses blunted impact of this improved diagnostic tool. During phased Xpert rollout in Botswana, we evaluated the impact of a package of interventions comprising (1) additional support for intensified TB case finding (ICF), (2) active tracing for patients missing clinic appointments to support retention, and (3) Xpert replacing sputum-smear microscopy, on early (6-month) antiretroviral therapy (ART) mortality. METHODS: At 22 clinics, ART enrollees > 12 years old were eligible for inclusion in three phases: a retrospective standard of care (SOC), prospective enhanced care (EC), and prospective EC plus Xpert (EC+X) phase. EC and EC+X phases were implemented as a stepped-wedge trial. Participants in the EC phase received SOC plus components 1 (strengthened ICF) and 2 (active tracing) of the intervention package, and participants in the EC+X phase received SOC plus all three intervention package components. Primary and secondary objectives were to compare all-cause 6-month ART mortality between SOC and EC+X and between EC and EC+X phases, respectively. We used adjusted analyses, appropriate for study design, to control for baseline differences in individual-level factors and intra-facility correlation. RESULTS: We enrolled 14,963 eligible patients: 8980 in SOC, 1768 in EC, and 4215 in EC+X phases. Median age of ART enrollees was 35 and 64% were female. Median CD4 cell count was lower in SOC than subsequent phases (184/μL in SOC, 246/μL in EC, and 241/μL in EC+X). By 6 months of ART, 461 (5.3%) of SOC, 54 (3.2%) of EC, and 121 (3.0%) of EC+X enrollees had died. Compared with SOC, 6-month mortality was lower in the EC+X phase (adjusted hazard ratio, 0.77; 95% confidence interval, 0.61-0.97, p = 0.029). Compared with EC enrollees, 6-month mortality was similar among EC+X enrollees. CONCLUSIONS: Interventions to strengthen ICF and retention were associated with lower early ART mortality. This new evidence highlights the need to strengthen ICF and retention in many similar settings. Similar to other trials, no additional mortality benefit of replacing sputum-smear microscopy with Xpert was observed. TRIAL REGISTRATION: Retrospectively registered: ClinicalTrials.gov (NCT02538952).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-019-1489-0

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Study design for the Xpert Package Rollout Evaluation using a Stepped-wedge design (XPRES). Abbreviations: SOC, standard of care phase; EC, enhanced care phase; EC+X, enhanced care plus Xpert phase
Fig. 1 Study design for the Xpert Package Rollout Evaluation using a Stepped-wedge design (XPRES). Abbreviations: SOC, standard of care phase; EC, enhanced care phase; EC+X, enhanced care plus Xpert phaseCC BY · PubMed Central
Fig. 2 Trial profile
Fig. 2 Trial profileCC BY · PubMed Central
Fig. 3 Kaplan-Meier curves showing cumulative 6-month mortality among ART enrollees in SOC, EC, and EC+X phases
Fig. 3 Kaplan-Meier curves showing cumulative 6-month mortality among ART enrollees in SOC, EC, and EC+X phasesCC BY · PubMed Central
Fig. 4 Intensified TB case finding (ICF) cascade among ART enrollees in SOC, EC, and EC+X phases. Abbreviations: SOC, standard of care phase, EC, enhanced care phase, EC+X, enhanced care plus Xpert phase
Fig. 4 Intensified TB case finding (ICF) cascade among ART enrollees in SOC, EC, and EC+X phases. Abbreviations: SOC, standard of care phase, EC, enhanced care phase, EC+X, enhanced care plus Xpert phaseCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 1

  1. Agizew T, Nyirenda S, Mathoma A, Mathebula U, Date A, Kgwaadira B, et al. Comparison of pre- and post-Xpert tuberculosis treatment outcomes among people living with HIV in Botswana. (Abstract # PC-1124-06). 46th World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease. Cape Town, 2–6 December 2015. Available at: https://theunion.org/what-we-do/journals/ijtld/body/Abstract_Book_2015-Web.pdf. Accessed 30 Nov 2019.

Cited by

See all 14

Metadata

Authors
Auld, A. F., Agizew, T., Mathoma, A., Boyd, R., Date, A., Pals, S. L., Serumola, C., Mathebula, U., Alexander, H., Ellerbrock, T. V., Rankgoane-Pono, G., Pono, P., Shepherd, J. C., Fielding, K., Grant, A. D., & Finlay, A.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Centers for Disease Control and Prevention (UG)
  • Ministry of Health (BW)
  • Yale University (US)
  • University of the Witwatersrand (ZA)
Corresponding author
Auld, Andrew F.
Venue
BMC Medicine
Published
2020-02-11
Volume
18
Issue
1
Pages
19-19
ISSN
1741-7015 (ISSN-L)
OpenAlex
W3012641266
Cited by
14
References
32
Citations by year
2026: 1 · 2025: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 7
FWCI
0.39
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
U.S. President’s Emergency Plan for AIDS Relief (Not applicable.)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords
tuberculosis screening, Xpert MTB/RIF, sputum smear microscopy, HIV/TB coinfection, patient retention, missed appointments, Botswana, health system capacity, CD4 count, stepped-wedge cluster randomized trial
MeSH terms
Adult, Botswana, Female, Humans, Male, Mass Screening, Mycobacterium tuberculosis, Prospective Studies, Tuberculosis, Survival Analysis, Anti-Retroviral Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial. https://app.cochat.ai/papers/10.1186/s12916-019-1489-0
The paper
Auld, A. F., Agizew, T., Mathoma, A., Boyd, R., Date, A., Pals, S. L., Serumola, C., Mathebula, U., Alexander, H., Ellerbrock, T. V., Rankgoane-Pono, G., Pono, P., Shepherd, J. C., Fielding, K., Grant, A. D., & Finlay, A. (2020). Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial. BMC Medicine. https://doi.org/10.1186/s12916-019-1489-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.